XML 31 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Mar. 31, 2017
Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (3,833,054) $ (899,378) $ (8,681,915) $ (8,173,389)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Provision for doubtful accounts, net of recoveries 6,642 167,496 385,597 435,838
Depreciation and amortization expense 155,267 164,658 645,742 351,396
Loss on disposal of assets     6,938 476,745
Deferred income taxes     40,188 (127,736)
Stock-based compensation expense 223,566 247,717 1,106,454 1,103,976
Gain on deconsolidation of variable interest entity     (242,411) 0
Loss on debt extinguishment     0 266,366
Amortization of deferred financing costs 53,667 37,926 44,806 94,912
Write-off of capitalized offering costs     0 513,646
Amortization adjustment to debt discount     0 (29,984)
Change in fair value of warrant and conversion feature liability 0 (822,222) (1,633,333) 408,692
Impairment of goodwill and intangible assets     68,311 207,285
Changes in assets and liabilities:        
Accounts receivable 76,212 (774,087) (2,780,122) (27,195)
Other receivables (342,063) 265,980 113,303 283,704
Due from affiliates 18,314 453 2,191 15,892
Prepaid expenses and other current assets (13,564) (215,182) (10,158) (92,182)
Restricted cash 19,941 0    
Deferred financing costs     0 (43,330)
Other assets 3,379 2,762 (8,916) 3,181
Accounts payable and accrued liabilities 8,329,610 (317,451) 3,653,211 1,024,991
Deferred rent liability (31,956) 33,584 53,514 57,907
Medical liabilities 17,949,904 (158,668) (902,478) 1,410,160
Net cash provided by (used in) operating activities 22,615,865 (2,266,412) (8,139,078) (1,839,125)
Cash flows from investing activities:        
Change in restricted cash     (235,058) 0
Proceeds from sale of ACC assets     0 15,000
Decrease in cash and cash equivalents resulting from deconsolidation of variable interest entities     (858,670) 0
Property and equipment acquired (36,081) (163,511) (297,561) (262,108)
Net cash used in investing activities (36,081) (163,511) (1,391,289) (247,108)
Cash flows from financing activities:        
Proceeds from issuance of convertible note payable     4,990,000 0
Proceeds from issuance of note payable - related party     5,000,000 0
Repayments on convertible notes     0 (470,000)
Proceeds from notes payable     400,000 100,000
Principal payments on notes payable     (400,000) (6,527,500)
Proceeds from line of credit     112,500 0
Principal Repayments on lines of credit (37,500) (12,500) (150,000) (1,006,000)
Distributions to non-controlling interest shareholder 0 (450,000) (1,200,000) (702,642)
Proceeds from the exercise of warrants and vested restricted stock 0 132,002 172,068 0
Proceeds from issuance of common stock     0 200,000
Payment to noncontrolling interest for equity interest     0 (251,852)
Net cash used in provided by financing activities (37,500) (330,498) 8,924,568 6,342,001
Net increase (decrease) in cash and cash equivalents 22,542,284 (2,760,421) (605,799) 4,255,768
Cash and cash equivalents, beginning of period 8,664,211 9,270,010 9,270,010 5,014,242
Cash and cash equivalents, end of period 31,206,495 6,509,589 8,664,211 9,270,010
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION:        
Interest paid 584 7,142 23,532 521,341
Income taxes paid $ 17,591 $ 16,400 30,902 176,587
NON-CASH FINANCING ACTIVITIES:        
Issuance of common stock on conversion of 8% warrants and notes     0 3,060,000
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest     0 553,851
Change in noncontrolling interest ownership     0 338,032
Tenant improvement allowance     0 659,360
Note receivable related to sale of ACC asset     0 51,000
Convertible debt reclassified to accounts payable     0 100,000
Common stock issued for acquisition of intangible assets     0 1,312,500
Reclassification of derivative liability to equity     1,177,778 0
Relative fair value of warrant included in debt discount     6,880 0
Reclassification of mezzanine equity to permanent equity     7,077,778 0
Reclassification of noncontrolling interest to due to acquisition of BAHA noncontrolling interest     183,408 0
Warrants issuable for debt guarantee     161,000 0
Series A Preferred Stock [Member]        
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss       0
Cash flows from financing activities:        
Proceeds from the issuance of preferred stock and warrants     0 10,000,000
NON-CASH FINANCING ACTIVITIES:        
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest       0
Series B Preferred Stock [Member]        
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss     0 0
Cash flows from financing activities:        
Proceeds from the issuance of preferred stock and warrants     $ 0 4,999,995
NON-CASH FINANCING ACTIVITIES:        
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest       $ 0